Sydney
Australia
HCV, direct-acting antivirals, correctional setting, injecting drug use, clinical trial
Hepatitis C virus, direct-acting antiviral therapy, modeling projections, HCV elimination, high-income setting, liver-related mortality, treatment scenarios